Nuvomedic Canna Consulting Ltd.

10/19/2026

10/18/2026

Curaleaf raises bid on Aurora in the fight for the global cannabis market

Curaleaf has increased its bid on Aurora Cannabis by 25 percent and extended the acceptance deadline to December 4.

The acquisition would unite Curaleaf's U.S. operations with Aurora's international medical cannabis business. But no agreement...

Read the full article: https://cannabisifokus.se/curaleaf-hojer-budet-pa-aurora-i-kampen-om-den-globala-cannabismarknaden/

10/16/2026

Eight Years of Legalization: Canada’s Abandoned Cannabis Policy and Unfinished Industry…

Eight years after historic legalization, the federal government has abandoned its Canada cannabis policy, leaving an unfinished and struggling industry.

10/14/2026

Cannabis has grown from less than $100 million in farm receipts in 2016 to more than $3 billion in 2025, making it Canada’s fifth-most important cash crop by total crop receipts.

It also ranked as the top crop by receipts in B.C. in 2025, with the province accounting for about $666.5 million, or 22% of Canada’s total cannabis crop receipts.

National and Provincial Highlights:

• National Ranking: Cannabis ranks as Canada’s fifth-largest cash crop by total crop receipts.

• British Columbia Leadership: B.C. leads the country as the top crop by receipts in the province, generating approximately $666.5 million—accounting for roughly 22% of all cannabis crop receipts nationwide.

• Tax Revenue Context: Cumulative tax revenue from legal cannabis products in Canada surpassed $5.4 billion between October 2018 and August 2025, with provincial and territorial governments collecting $4.2 billion and the federal government collecting $1.2 billion.

https://stratcann.com/news/cannabis-becomes-canadas-fifth-most-important-cash-crop/

10/09/2026

Key Benefits for Crohn's Patients. Many patients turn to medical cannabis as a complementary therapy alongside standard medical care to relieve severe daily symptoms:

* Pain Management: It effectively dulls abdominal cramping and chronic pain.

* Nausea and Appetite: It reduces nausea and helps counteract weight loss by boosting appetite.

* Bowel Regulation: It can help reduce bowel
movement frequency by altering intestinal motility.

* Improved Sleep & Well-being: Patients frequently report improved sleep patterns and a better overall sense of well-being.

Resource: https://www.medicuscannabus.com/blog/calming-the-inflammation-the-science-behind-medical-marijuanas-role-in-crohns-disease

10/06/2026

Cannabis treatment is associated with significant decreases in endometriosis patients' pain intensity and frequency, as well as reductions in their reliance on prescription analgesics.

Patients also experienced improvements in their emotional well-being, fatigue, anxiety, daily functionality, and overall quality of life.

🔗 Read more: https://norml.org/news/2026/10/01/observational-study-adjunctive-use-of-oral-cannabis-provides-clinically-meaningful-improvements-in-endometriosis-patients/

09/24/2026

Neurodegeneration doesn’t start when symptoms show up - it begins when protection breaks down, when inflammation builds, and when the brain’s own barrier starts losing control. That’s where this paper hits different, because it doesn’t just look at neurons, it looks at what’s supposed to protect them in the first place.

In "Cannabinoids, the Blood–Brain Barrier, and Neurodegeneration: Mechanisms, Dysregulation, and Therapeutic Perspectives" (2026), the focus shifts to how cannabinoids interact with the blood-brain barrier and the systems that regulate what enters the brain.

That matters because once that barrier weakens, inflammatory signals and oxidative stress don’t just increase - they gain access.

What stands out is how cannabinoids may support barrier integrity while also reducing neuroinflammation and oxidative damage at the same time. That’s not a one-lane effect, that’s layered regulation. The review connects CB1, CB2, TRP channels, and broader signaling pathways to how the brain maintains balance under stress, and what happens when that balance starts slipping.

The real takeaway stays grounded - this is strong mechanistic insight with growing therapeutic relevance, but it’s not a finished clinical playbook. It’s a direction.

A signal that protecting the brain may depend on supporting the systems that protect it first, before degeneration takes hold.

-Mike Robinson, Global Cannabinoid Research Center

Study: https://www.mdpi.com/2218-273X/16/2/225